| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.083 | 0.04 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.12 | 0.04 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.04 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.076 | 0.04 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |